HealthLynked Statistics
Total Valuation
HealthLynked has a market cap or net worth of 8.12 million. The enterprise value is 16.19 million.
| Market Cap | 8.12M |
| Enterprise Value | 16.19M |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HealthLynked has 2.95 million shares outstanding. The number of shares has increased by 2.40% in one year.
| Current Share Class | 2.95M |
| Shares Outstanding | 2.95M |
| Shares Change (YoY) | +2.40% |
| Shares Change (QoQ) | +1.38% |
| Owned by Insiders (%) | 32.13% |
| Owned by Institutions (%) | 0.00% |
| Float | 2.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.92 |
| PB Ratio | -1.05 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 11.80 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.17
| Current Ratio | 0.17 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -5.63 |
| Interest Coverage | -4.19 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -83.54% |
| Return on Invested Capital (ROIC) | -382.40% |
| Return on Capital Employed (ROCE) | 31.49% |
| Weighted Average Cost of Capital (WACC) | 9.63% |
| Revenue Per Employee | 171,502 |
| Profits Per Employee | -500,704 |
| Employee Count | 10 |
| Asset Turnover | 0.80 |
| Inventory Turnover | 27.74 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.03% in the last 52 weeks. The beta is 1.75, so HealthLynked's price volatility has been higher than the market average.
| Beta (5Y) | 1.75 |
| 52-Week Price Change | -8.03% |
| 50-Day Moving Average | 2.88 |
| 200-Day Moving Average | 2.64 |
| Relative Strength Index (RSI) | 48.12 |
| Average Volume (20 Days) | 1,871 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.21 |
Income Statement
In the last 12 months, HealthLynked had revenue of 1.37 million and -4.01 million in losses. Loss per share was -1.39.
| Revenue | 1.37M |
| Gross Profit | 735,606 |
| Operating Income | -2.30M |
| Pretax Income | -3.97M |
| Net Income | -4.01M |
| EBITDA | -2.22M |
| EBIT | -2.30M |
| Loss Per Share | -1.39 |
Balance Sheet
The company has 12,844 in cash and 8.08 million in debt, with a net cash position of -8.07 million or -2.73 per share.
| Cash & Cash Equivalents | 12,844 |
| Total Debt | 8.08M |
| Net Cash | -8.07M |
| Net Cash Per Share | -2.73 |
| Equity (Book Value) | -7.75M |
| Book Value Per Share | -2.63 |
| Working Capital | -7.35M |
Cash Flow
| Operating Cash Flow | -1.44M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 82,878 |
| Net Borrowing | 1.28M |
| Free Cash Flow | -1.44M |
| FCF Per Share | -0.49 |
Margins
Gross margin is 53.61%, with operating and profit margins of -167.64% and -289.30%.
| Gross Margin | 53.61% |
| Operating Margin | -167.64% |
| Pretax Margin | -289.30% |
| Profit Margin | -289.30% |
| EBITDA Margin | -161.60% |
| EBIT Margin | -167.64% |
| FCF Margin | n/a |
Dividends & Yields
HealthLynked does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.40% |
| Shareholder Yield | -2.40% |
| Earnings Yield | -49.32% |
| FCF Yield | -17.68% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 4, 2025. It was a reverse split with a ratio of 0.01.
| Last Split Date | Sep 4, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.01 |
Scores
HealthLynked has an Altman Z-Score of -55.54 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -55.54 |
| Piotroski F-Score | 3 |